IPAD: the Integrated Pathway Analysis Database for Systematic Enrichment Analysis.

Authors:
Fan Zhang
Fan Zhang
School of Pharmacy
Madison | United States
Renee Drabier
Renee Drabier
University of North Texas Health Science Center

BMC Bioinformatics 2012 11;13 Suppl 15:S7. Epub 2012 Sep 11.

Department of Academic and Institutional Resources and Technology, University of North Texas Health Science Center, Fort Worth, USA.

Background: Next-Generation Sequencing (NGS) technologies and Genome-Wide Association Studies (GWAS) generate millions of reads and hundreds of datasets, and there is an urgent need for a better way to accurately interpret and distill such large amounts of data. Extensive pathway and network analysis allow for the discovery of highly significant pathways from a set of disease vs. healthy samples in the NGS and GWAS. Knowledge of activation of these processes will lead to elucidation of the complex biological pathways affected by drug treatment, to patient stratification studies of new and existing drug treatments, and to understanding the underlying anti-cancer drug effects. There are approximately 141 biological human pathway resources as of Jan 2012 according to the Pathguide database. However, most currently available resources do not contain disease, drug or organ specificity information such as disease-pathway, drug-pathway, and organ-pathway associations. Systematically integrating pathway, disease, drug and organ specificity together becomes increasingly crucial for understanding the interrelationships between signaling, metabolic and regulatory pathway, drug action, disease susceptibility, and organ specificity from high-throughput omics data (genomics, transcriptomics, proteomics and metabolomics).

Results: We designed the Integrated Pathway Analysis Database for Systematic Enrichment Analysis (IPAD, http://bioinfo.hsc.unt.edu/ipad), defining inter-association between pathway, disease, drug and organ specificity, based on six criteria: 1) comprehensive pathway coverage; 2) gene/protein to pathway/disease/drug/organ association; 3) inter-association between pathway, disease, drug, and organ; 4) multiple and quantitative measurement of enrichment and inter-association; 5) assessment of enrichment and inter-association analysis with the context of the existing biological knowledge and a "gold standard" constructed from reputable and reliable sources; and 6) cross-linking of multiple available data sources.IPAD is a comprehensive database covering about 22,498 genes, 25,469 proteins, 1956 pathways, 6704 diseases, 5615 drugs, and 52 organs integrated from databases including the BioCarta, KEGG, NCI-Nature curated, Reactome, CTD, PharmGKB, DrugBank, PharmGKB, and HOMER. The database has a web-based user interface that allows users to perform enrichment analysis from genes/proteins/molecules and inter-association analysis from a pathway, disease, drug, and organ.Moreover, the quality of the database was validated with the context of the existing biological knowledge and a "gold standard" constructed from reputable and reliable sources. Two case studies were also presented to demonstrate: 1) self-validation of enrichment analysis and inter-association analysis on brain-specific markers, and 2) identification of previously undiscovered components by the enrichment analysis from a prostate cancer study.

Conclusions: IPAD is a new resource for analyzing, identifying, and validating pathway, disease, drug, organ specificity and their inter-associations. The statistical method we developed for enrichment and similarity measurement and the two criteria we described for setting the threshold parameters can be extended to other enrichment applications. Enriched pathways, diseases, drugs, organs and their inter-associations can be searched, displayed, and downloaded from our online user interface. The current IPAD database can help users address a wide range of biological pathway related, disease susceptibility related, drug target related and organ specificity related questions in human disease studies.

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2105-13-S15-S7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3439721PMC

Still can't find the full text of the article?

We can help you send a request to the authors directly.
April 2013
79 Reads

Article Mentions


Provided by Crossref Event Data
web
Web: Web
March 22, 2017, 10:19 am EST

Publication Analysis

Top Keywords

disease drug
24
organ specificity
24
pathway disease
24
drug organ
20
enrichment analysis
20
inter-association analysis
12
pathway
12
analysis
11
drug
11
disease
10
enrichment
9
standard" constructed
8
"gold standard"
8
constructed reputable
8
drugs organs
8
reputable reliable
8
knowledge "gold
8
enrichment inter-association
8
inter-association pathway
8
disease susceptibility
8

References

(Supplied by CrossRef)

S LOHR et al.
2012

A Pollack et al.
2011
Article in Nucleic Acids Res
GD Bader et al.
Nucleic Acids Res 2006
Article in Neuropsychol Dev Cogn B Aging Neuropsychol Cogn
CA Luis et al.
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 2009
Article in PloS one
KG Victor et al.
PloS one 2012
Article in Nucleic Acids Res
CF Schaefer et al.
Nucleic Acids Res 2009
Article in Nucleic Acids Res
D Croft et al.
Nucleic Acids Res 2011
Article in Nucleic Acids Res
T Kelder et al.
Nucleic Acids Res 2012
Article in BMC Bioinformatics
SR Chowbina et al.
BMC Bioinformatics 2009
Article in Mol Syst Biol
A Bauer-Mehren et al.
Mol Syst Biol 2009
Article in Nucleic Acids Res
N Yu et al.
Nucleic Acids Res 2012

Similar Publications